U.S. markets open in 7 hours 16 minutes
  • S&P Futures

    4,169.50
    -3.25 (-0.08%)
     
  • Dow Futures

    34,125.00
    -65.00 (-0.19%)
     
  • Nasdaq Futures

    13,190.00
    -19.75 (-0.15%)
     
  • Russell 2000 Futures

    1,806.00
    -2.70 (-0.15%)
     
  • Crude Oil

    82.55
    +0.39 (+0.47%)
     
  • Gold

    2,056.80
    +1.50 (+0.07%)
     
  • Silver

    26.01
    +0.09 (+0.33%)
     
  • EUR/USD

    1.1073
    +0.0024 (+0.22%)
     
  • 10-Yr Bond

    3.4520
    0.0000 (0.00%)
     
  • Vix

    17.80
    -1.29 (-6.76%)
     
  • GBP/USD

    1.2540
    +0.0014 (+0.11%)
     
  • USD/JPY

    132.4200
    -0.1470 (-0.11%)
     
  • Bitcoin USD

    30,769.34
    +666.90 (+2.22%)
     
  • CMC Crypto 200

    685.33
    +30.23 (+4.62%)
     
  • FTSE 100

    7,843.38
    +18.54 (+0.24%)
     
  • Nikkei 225

    28,499.82
    +342.85 (+1.22%)
     

Does The Market Have A Low Tolerance For Jenoptik AG's (ETR:JEN) Mixed Fundamentals?

  • Oops!
    Something went wrong.
    Please try again later.
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Jenoptik (ETR:JEN) has had a rough month with its share price down 6.5%. It is possible that the markets have ignored the company's differing financials and decided to lean-in to the negative sentiment. Fundamentals usually dictate market outcomes so it makes sense to study the company's financials. In this article, we decided to focus on Jenoptik's ROE.

Return on equity or ROE is a key measure used to assess how efficiently a company's management is utilizing the company's capital. Put another way, it reveals the company's success at turning shareholder investments into profits.

See our latest analysis for Jenoptik

How Do You Calculate Return On Equity?

The formula for return on equity is:

Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity

So, based on the above formula, the ROE for Jenoptik is:

7.6% = €64m ÷ €843m (Based on the trailing twelve months to December 2022).

The 'return' is the income the business earned over the last year. So, this means that for every €1 of its shareholder's investments, the company generates a profit of €0.08.

What Has ROE Got To Do With Earnings Growth?

Thus far, we have learned that ROE measures how efficiently a company is generating its profits. Based on how much of its profits the company chooses to reinvest or "retain", we are then able to evaluate a company's future ability to generate profits. Assuming everything else remains unchanged, the higher the ROE and profit retention, the higher the growth rate of a company compared to companies that don't necessarily bear these characteristics.

A Side By Side comparison of Jenoptik's Earnings Growth And 7.6% ROE

When you first look at it, Jenoptik's ROE doesn't look that attractive. However, given that the company's ROE is similar to the average industry ROE of 7.6%, we may spare it some thought. But then again, Jenoptik's five year net income shrunk at a rate of 3.2%. Remember, the company's ROE is a bit low to begin with. So that's what might be causing earnings growth to shrink.

However, when we compared Jenoptik's growth with the industry we found that while the company's earnings have been shrinking, the industry has seen an earnings growth of 3.4% in the same period. This is quite worrisome.

past-earnings-growth
past-earnings-growth

The basis for attaching value to a company is, to a great extent, tied to its earnings growth. What investors need to determine next is if the expected earnings growth, or the lack of it, is already built into the share price. Doing so will help them establish if the stock's future looks promising or ominous. If you're wondering about Jenoptik's's valuation, check out this gauge of its price-to-earnings ratio, as compared to its industry.

Is Jenoptik Efficiently Re-investing Its Profits?

When we piece together Jenoptik's low three-year median payout ratio of 18% (where it is retaining 82% of its profits), calculated for the last three-year period, we are puzzled by the lack of growth. The low payout should mean that the company is retaining most of its earnings and consequently, should see some growth. It looks like there might be some other reasons to explain the lack in that respect. For example, the business could be in decline.

Moreover, Jenoptik has been paying dividends for at least ten years or more suggesting that management must have perceived that the shareholders prefer dividends over earnings growth. Our latest analyst data shows that the future payout ratio of the company over the next three years is expected to be approximately 21%. Still, forecasts suggest that Jenoptik's future ROE will rise to 12% even though the the company's payout ratio is not expected to change by much.

Summary

Overall, we have mixed feelings about Jenoptik. While the company does have a high rate of profit retention, its low rate of return is probably hampering its earnings growth. Having said that, looking at current analyst estimates, we found that the company's earnings growth rate is expected to see a huge improvement. To know more about the latest analysts predictions for the company, check out this visualization of analyst forecasts for the company.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Join A Paid User Research Session
You’ll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here